Thomas L Gallagher

8PUBLICATIONS

24CO-AUTHORS

Gene and molecular therapyGenetically modified animalsAnthropology of developmentTe mātauranga taihara Māori (Māori criminology)Medical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 25, 2026

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model.

|May 23, 2026

Long-term comparative analysis of AAV9-mediated gene replacement therapies for spinal muscular atrophy in mice.

|Apr 14, 2026

Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.

Shestruma Parajuli, Thomas Gallagher, Terence R Flotte

|Aug 15, 2025

Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial.

Florian Eichler, Oguz I Cataltepe, Rrita Daci

|May 20, 2025

European Society of Gene & Cell Therapy Spring School 2025.

Thomas Gallagher

|Apr 07, 2025

Interview with Chiara Bonini, MD.

Thomas Gallagher

Pageof 2

Frequent Collaborators

Terence R Flotte

Jun Xie

Allison M Keeler

Guangping Gao

Xiupeng Chen

Heather L Gray-Edwards

Zhao Zhang

Philipp E Scherer

Jessica A Chichester

Mohammed Salman Shazeeb

Frequent Collaborators

Terence R Flotte

Jun Xie

Allison M Keeler

Guangping Gao